Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]

ASEM 文献综述

Official National Advisory Committee on Immunization document (2022) on “Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]”. NACI recommendations for use of the recombinant protein subunit COVID-19 vaccine Novavax Nuvaxovid: Methods, epidemiology, vaccine characteristics, clinical data, administration, safety, adverse events and more.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。